The usual cause for the fund is to invest in rounds with 3 partakers. The meaningful sponsors for the fund in investment in the same round are Xeraya Capital, JP Asia Prime Capital.
Among the most popular fund investment industries, there are Biotechnology, Therapeutics. Among the most popular portfolio startups of the fund, we may highlight PrIME Biologics. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.
The high activity for fund was in 2014. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars.
| Fund Name | Location |
| CHET Marketing | Japan, Tokyo |
| Engel Ventures | California, Santa Barbara, United States |
| Eteron VC | Greater Poland Voivodeship, Poland, Poznań |
| Fastlane Ventures | Cyprus, Limassol |
| Fuva Brain | Japan, Tokyo |
| J-Tech Capital | Canada, Ontario, Toronto |
| Kokopelli Capital | - |
| Madison Bay Capital Partners | New York, New York, United States |
| Martin Companies | Kilgore, Texas, United States |
| Murphy Family Ventures | - |
| Ningbo Huitian Hede Xinxi | China, Ningbo, Zhejiang |
| Novel Bioventures | Gaithersburg, Maryland, United States |
| Nuclio Venture Builder | Barcelona, Catalonia, Spain |
| RPD Innovations | Ar Riyad, Riyadh, Saudi Arabia |
| Rugged Ventures | New York, New York, United States |
| Shanghai Xinhushang Shiye Jituan Touzi Gufen Youxian Gongsi | China, Hongkou District |
| Sime Darby | Kuala Lumpur, Malaysia |
| Southpaw Asset Management | Connecticut, Greenwich, United States |
| SRS Investment Management | New York, New York, United States |
| Xingyu Touzi | China, Jiangsu, Jintan |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 